PYLUM BIOSCIENCES, INC.

Address: 100 KIMBALL WAY SOUTH SAN FRANCISCO, CA 94080-6218
County: SAN MATEO
Country: UNITED STATES
UEI: LLANDDLF1151

Issue Date FY

Legal Entity Zip Code

Issue Date FY: 2023 ( Subtotal = -$8,395 )

2023

2020

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

005

NIH

12/13/2022

-$8,395

2023

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

004

NIH

12/5/2022

$30,409

2023

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

001

NIH

11/29/2022

-$30,409

Issue Date FY: 2022 ( Subtotal = $30,409 )

2022

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

004

NIH

9/8/2022

$255

2022

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

002

NIH

8/23/2022

$30

2022

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

006

NIH

9/27/2022

-$510

2022

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

001

NIH

8/19/2022

$30,634

Issue Date FY: 2021 ( Subtotal = -$115,778 )

2021

2020

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

001

NIH

10/22/2020

-$115,778

2021

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

000

NIH

10/21/2020

Issue Date FY: 2020 ( Subtotal = $525,456 )

2020

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

000

NIH

5/21/2020

$525,456

Issue Date FY: 2019 ( Subtotal = $530,308 )

2019

PYLUM BIOSCIENCES, INC.

100 KIMBALL WAY

SOUTH SAN FRANCISCO

94080-6218

SAN MATEO

USA

R33AI121692

Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.

001

NIH

6/20/2019

$530,308

All Categories

About

Search

Reports

Data Submission

Recipient Information

PYLUM BIOSCIENCES, INC.

Address: 100 KIMBALL WAY SOUTH SAN FRANCISCO, CA 94080-6218

County: SAN MATEO

Country: UNITED STATES

UEI: LLANDDLF1151

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer